VCBD Stock Overview
Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Vitalibis, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | 0% |
| 5 Year Change | -99.96% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| VCBD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | 0% | 13.1% | 30.7% |
Return vs Industry: VCBD underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: VCBD underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| VCBD volatility | |
|---|---|
| VCBD Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VCBD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine VCBD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Steve Raack | www.vitalibis.com |
Vitalibis, Inc. operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. The company markets and sells consumer products under the Vitalibis brand. It also sells water soluble phytocannabinoid rich hemp powder.
Vitalibis, Inc. Fundamentals Summary
| VCBD fundamental statistics | |
|---|---|
| Market cap | US$34.59k |
| Earnings (TTM) | -US$3.96m |
| Revenue (TTM) | US$243.57k |
0.0x
P/S Ratio0.0x
P/E RatioIs VCBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VCBD income statement (TTM) | |
|---|---|
| Revenue | US$243.57k |
| Cost of Revenue | US$117.98k |
| Gross Profit | US$125.59k |
| Other Expenses | US$4.08m |
| Earnings | -US$3.96m |
Last Reported Earnings
Sep 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VCBD perform over the long term?
See historical performance and comparison